Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors

Consensus Round Table, Scottsdale (Arizona), March 22, 1987

  • T. M. O’Dorisio
Conference proceedings

Table of contents

  1. Front Matter
    Pages I-VIII
  2. T. M. O’Dorisio
    Pages 1-2
  3. H. F. Woods, N. D. S. Bax, J. A. C. Thorpe, J. A. R. Smith
    Pages 15-22
  4. T. S. Gaginella, T. M. O’Dorisio, H. S. Mekhjian, M. S. O’Dorisio, E. A. Woltering
    Pages 23-38
  5. T. M. O’Dorisio, T. S. Gaginella, M. S. O’Dorisio, R. W. Meleca, D. A. Wray, K. Osei
    Pages 43-48
  6. J. A. Chayvialle, J. C. Souquet, G. Sassolas, C. Partensky
    Pages 49-52
  7. G. J. Krejs
    Pages 53-57
  8. K. Gyr, A. Koelz, M. Kraenzlin, C. Beglinger, V. Meier, S. R. Bloom
    Pages 59-60
  9. M. J. Dunne, R. Elton, T. Fletcher, P. Hofker, J. Shui
    Pages 93-113
  10. T. M. O’Dorisio
    Pages 115-117
  11. T. M. O’Dorisio
    Pages 119-120
  12. Back Matter
    Pages 121-146

About these proceedings


The secretion of bioactive products by tumors of the gastroenteropancreatic system results in the development of watery diarrhea that can lead to death in a very short period if not brought under control. Even if the consequences are less dramatic, the patients' ability to lead a normal daily life is seriously impaired, and they may become severely depressed. SandostatinR alleviates the condition by inhibiting peptide release, and its long duration of action makes it an effective and rational adjunct to therapy at all stages. Last year a consensus Round Table Meeting was held in Scottsdale, Arizona, to discuss the optimal use of SandostatinR in this indication. These guidelines offer the results of clinical research and the dosage recommendations arising from them, together with a critical summary of the points of view presented.


carcinoma cell clinical research lead research therapy treatment tumor

Editors and affiliations

  • T. M. O’Dorisio
    • 1
  1. 1.College of Medicine, Department of EndocrinologyThe Ohio State UniversityColumbusUSA

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1989
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-64794-9
  • Online ISBN 978-3-642-61328-9
  • Buy this book on publisher's site